| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 1, 2026 | ±3.1% | -2.5% | over-priced |
| October 31, 2025 | ±5.3% | -0.6% | over-priced |
| August 1, 2025 | ±4.9% | -1.3% | over-priced |
| May 2, 2025 | ±3.2% | +0.6% | over-priced |
| August 2, 2024 | ±4.6% | -3.5% | over-priced |
| May 3, 2024 | ±4.8% | +0.3% | over-priced |
| November 3, 2023 | ±2.6% | +0.3% | over-priced |
| August 4, 2023 | ±2.4% | +0.3% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $1.22 | $4.0B | $147M |
| Q4 FY2025 | $1.12 | $3.9B | $136M |
| Q3 FY2025 | $1.34 | $4.1B | $163M |
| Q2 FY2025 | $1.26 | $4.1B | $152M |
C.H. Robinson Worldwide, Inc. (CHRW) reports in 116 days, with the next report estimated for October 7, 2026. Across the last 8 reports, options priced an average ±3.9% earnings move while the stock actually moved 1.2% on average — the market has systematically over-priced CHRW's earnings risk. Fundamentals into the print: EPS up 9.9% year-over-year, revenue down 0.8%. QuantLogix's live 5-factor engine currently reads CHRW as a buy at 62/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →